|
JP2576862B2
(ja)
*
|
1986-03-05 |
1997-01-29 |
大塚製薬 株式会社 |
カルボスチリル誘導体
|
|
JPS63301821A
(ja)
*
|
1986-03-05 |
1988-12-08 |
Otsuka Pharmaceut Co Ltd |
抗不整脈剤
|
|
US5358949A
(en)
*
|
1986-03-05 |
1994-10-25 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
|
|
US5464833A
(en)
*
|
1992-08-19 |
1995-11-07 |
Otsuka Pharmaceutical Co., Ltd. |
Apoptosis regulating composition
|
|
EP2621923B1
(en)
*
|
2010-09-29 |
2017-03-29 |
Intervet International B.V. |
N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
|
|
HK1203412A1
(en)
|
2011-12-28 |
2015-10-30 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
SG10201912411RA
(en)
|
2011-12-28 |
2020-02-27 |
Univ California |
Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
BR112015021982B1
(pt)
|
2013-03-15 |
2022-12-13 |
Global Blood Therapeutics, Inc |
Compostos e seus usos para a modulação de hemoglobina
|
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EP2970196B1
(en)
|
2013-03-15 |
2020-11-25 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
KR20150132146A
(ko)
|
2013-03-15 |
2015-11-25 |
글로벌 블러드 테라퓨틱스, 인크. |
헤모글로빈 조정을 위한 화합물 및 이의 용도
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9422279B2
(en)
|
2013-03-15 |
2016-08-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
FI3102208T4
(fi)
|
2014-02-07 |
2024-09-23 |
Global Blood Therapeutics Inc |
2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi
|
|
WO2017096230A1
(en)
|
2015-12-04 |
2017-06-08 |
Global Blood Therapeutics, Inc. |
Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
AR108435A1
(es)
|
2016-05-12 |
2018-08-22 |
Global Blood Therapeutics Inc |
Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
|
|
TW202332423A
(zh)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
ES2966707T3
(es)
|
2018-10-01 |
2024-04-23 |
Global Blood Therapeutics Inc |
Moduladores de la hemoglobina para el tratamiento de la drepanocitosis
|